Delphinus Medical Technologies

About:

Delphinus Medical Technologies develops, commercializes, and services breast cancer screening solutions to hospitals and imaging clinics.

Website: http://www.delphinusmt.com

Top Investors: Trinity Capital, Beringea, Arboretum Ventures, Venture Investors, Hopen Life Science Ventures

Description:

Delphinus Medical Technologies develops, commercializes, sells, and services breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy.

Total Funding Amount:

$109M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Novi, Michigan, United States

Founded Date:

2010-01-01

Founders:

Neb Duric, Peter J. Littrup

Number of Employees:

51-100

Last Funding Date:

2023-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai